The utility of yeast as a tool for cell-based, target-directed high-throughput screening

Many Neglected Tropical Diseases (NTDs) have recently been subject of increased focus, particularly with relation to high-throughput screening (HTS) initiatives. These vital endeavours largely rely of two approaches, in vitro target-directed screening using biochemical assays or cell-based screening...

Full description

Saved in:
Bibliographic Details
Published inParasitology Vol. 141; no. 1; pp. 8 - 16
Main Authors NORCLIFFE, J. L., ALVAREZ-RUIZ, E., MARTIN-PLAZA, J. J., STEEL, P. G., DENNY, P. W.
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 01.01.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Many Neglected Tropical Diseases (NTDs) have recently been subject of increased focus, particularly with relation to high-throughput screening (HTS) initiatives. These vital endeavours largely rely of two approaches, in vitro target-directed screening using biochemical assays or cell-based screening which takes no account of the target or targets being hit. Despite their successes both of these approaches have limitations; for example, the production of soluble protein and a lack of cellular context or the problems and expense of parasite cell culture. In addition, both can be challenging to miniaturize for ultra (u)HTS and expensive to utilize. Yeast-based systems offer a cost-effective approach to study and screen protein targets in a direct-directed manner within a eukaryotic cellular context. In this review, we examine the utility and limitations of yeast cell-based, target-directed screening. In particular we focus on the currently under-explored possibility of using such formats in uHTS screening campaigns for NTDs.
Bibliography:http://dx.doi.org/10.1017/S0031182013000425
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0031-1820
1469-8161
1469-8161
DOI:10.1017/S0031182013000425